Novavax, Inc. (NVAX)
8.84
+0.20
(+2.31%)
USD |
NASDAQ |
Apr 17, 16:00
8.71
-0.13
(-1.47%)
After-Hours: 06:57
Novavax SG&A Expense (Quarterly) : 34.12M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |
| Moderna, Inc. | 308.00M |
| Intellia Therapeutics, Inc. | 33.08M |
| Recursion Pharmaceuticals, Inc. | 33.66M |